Global Flunixin Meglumine Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 115
Published Date: 10 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Flunixin Meglumine Injection market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Flunixin Meglumine Injection is used for febrile diseases, muscle pain and soft tissue pain of livestock and small animals
The Global Info Research report includes an overview of the development of the Flunixin Meglumine Injection industry chain, the market status of Animal muscle pain (10ml/Dose, 20ml/ Dose), Animal febrile disease (10ml/Dose, 20ml/ Dose), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Flunixin Meglumine Injection.
Regionally, the report analyzes the Flunixin Meglumine Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Flunixin Meglumine Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Flunixin Meglumine Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Flunixin Meglumine Injection industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., 10ml/Dose, 20ml/ Dose).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Flunixin Meglumine Injection market.
Regional Analysis: The report involves examining the Flunixin Meglumine Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Flunixin Meglumine Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Flunixin Meglumine Injection:
Company Analysis: Report covers individual Flunixin Meglumine Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Flunixin Meglumine Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Animal muscle pain, Animal febrile disease).
Technology Analysis: Report covers specific technologies relevant to Flunixin Meglumine Injection. It assesses the current state, advancements, and potential future developments in Flunixin Meglumine Injection areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Flunixin Meglumine Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Flunixin Meglumine Injection market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
10ml/Dose
20ml/ Dose
Market segment by Application
Animal muscle pain
Animal febrile disease
Others
Major players covered
Norbrook
Zoteis
Merck Animal Health
Virbac Animal Health India Private Limited
MSD Animal Health
Bengal Remedies Limited
Wuhan Huisheng Biological Technology Co., Ltd.
Qilu Animal Health Products Co., Ltd.
Baimukang Animal Pharmaceutical Co., Ltd.
Shandong Zhongmu Veterinary Medicine Co., Ltd.
Hebei New Century Pharmaceutical Co., Ltd.
Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Flunixin Meglumine Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Flunixin Meglumine Injection, with price, sales, revenue and global market share of Flunixin Meglumine Injection from 2019 to 2024.
Chapter 3, the Flunixin Meglumine Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Flunixin Meglumine Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Flunixin Meglumine Injection market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Flunixin Meglumine Injection.
Chapter 14 and 15, to describe Flunixin Meglumine Injection sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Flunixin Meglumine Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Flunixin Meglumine Injection Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 10ml/Dose
1.3.3 20ml/ Dose
1.4 Market Analysis by Application
1.4.1 Overview: Global Flunixin Meglumine Injection Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Animal muscle pain
1.4.3 Animal febrile disease
1.4.4 Others
1.5 Global Flunixin Meglumine Injection Market Size & Forecast
1.5.1 Global Flunixin Meglumine Injection Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Flunixin Meglumine Injection Sales Quantity (2019-2030)
1.5.3 Global Flunixin Meglumine Injection Average Price (2019-2030)
2.1 Norbrook
2.1.1 Norbrook Details
2.1.2 Norbrook Major Business
2.1.3 Norbrook Flunixin Meglumine Injection Product and Services
2.1.4 Norbrook Flunixin Meglumine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Norbrook Recent Developments/Updates
2.2 Zoteis
2.2.1 Zoteis Details
2.2.2 Zoteis Major Business
2.2.3 Zoteis Flunixin Meglumine Injection Product and Services
2.2.4 Zoteis Flunixin Meglumine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Zoteis Recent Developments/Updates
2.3 Merck Animal Health
2.3.1 Merck Animal Health Details
2.3.2 Merck Animal Health Major Business
2.3.3 Merck Animal Health Flunixin Meglumine Injection Product and Services
2.3.4 Merck Animal Health Flunixin Meglumine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Animal Health Recent Developments/Updates
2.4 Virbac Animal Health India Private Limited
2.4.1 Virbac Animal Health India Private Limited Details
2.4.2 Virbac Animal Health India Private Limited Major Business
2.4.3 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product and Services
2.4.4 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Virbac Animal Health India Private Limited Recent Developments/Updates
2.5 MSD Animal Health
2.5.1 MSD Animal Health Details
2.5.2 MSD Animal Health Major Business
2.5.3 MSD Animal Health Flunixin Meglumine Injection Product and Services
2.5.4 MSD Animal Health Flunixin Meglumine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 MSD Animal Health Recent Developments/Updates
2.6 Bengal Remedies Limited
2.6.1 Bengal Remedies Limited Details
2.6.2 Bengal Remedies Limited Major Business
2.6.3 Bengal Remedies Limited Flunixin Meglumine Injection Product and Services
2.6.4 Bengal Remedies Limited Flunixin Meglumine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bengal Remedies Limited Recent Developments/Updates
2.7 Wuhan Huisheng Biological Technology Co., Ltd.
2.7.1 Wuhan Huisheng Biological Technology Co., Ltd. Details
2.7.2 Wuhan Huisheng Biological Technology Co., Ltd. Major Business
2.7.3 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product and Services
2.7.4 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Wuhan Huisheng Biological Technology Co., Ltd. Recent Developments/Updates
2.8 Qilu Animal Health Products Co., Ltd.
2.8.1 Qilu Animal Health Products Co., Ltd. Details
2.8.2 Qilu Animal Health Products Co., Ltd. Major Business
2.8.3 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product and Services
2.8.4 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Qilu Animal Health Products Co., Ltd. Recent Developments/Updates
2.9 Baimukang Animal Pharmaceutical Co., Ltd.
2.9.1 Baimukang Animal Pharmaceutical Co., Ltd. Details
2.9.2 Baimukang Animal Pharmaceutical Co., Ltd. Major Business
2.9.3 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services
2.9.4 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Baimukang Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
2.10 Shandong Zhongmu Veterinary Medicine Co., Ltd.
2.10.1 Shandong Zhongmu Veterinary Medicine Co., Ltd. Details
2.10.2 Shandong Zhongmu Veterinary Medicine Co., Ltd. Major Business
2.10.3 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product and Services
2.10.4 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Developments/Updates
2.11 Hebei New Century Pharmaceutical Co., Ltd.
2.11.1 Hebei New Century Pharmaceutical Co., Ltd. Details
2.11.2 Hebei New Century Pharmaceutical Co., Ltd. Major Business
2.11.3 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services
2.11.4 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hebei New Century Pharmaceutical Co., Ltd. Recent Developments/Updates
2.12 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
2.12.1 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Details
2.12.2 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Major Business
2.12.3 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services
2.12.4 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
2.13 Shandong Lukang Pharmaceutical Co., Ltd.
2.13.1 Shandong Lukang Pharmaceutical Co., Ltd. Details
2.13.2 Shandong Lukang Pharmaceutical Co., Ltd. Major Business
2.13.3 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services
2.13.4 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments/Updates
3.1 Global Flunixin Meglumine Injection Sales Quantity by Manufacturer (2019-2024)
3.2 Global Flunixin Meglumine Injection Revenue by Manufacturer (2019-2024)
3.3 Global Flunixin Meglumine Injection Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Flunixin Meglumine Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Flunixin Meglumine Injection Manufacturer Market Share in 2023
3.4.2 Top 6 Flunixin Meglumine Injection Manufacturer Market Share in 2023
3.5 Flunixin Meglumine Injection Market: Overall Company Footprint Analysis
3.5.1 Flunixin Meglumine Injection Market: Region Footprint
3.5.2 Flunixin Meglumine Injection Market: Company Product Type Footprint
3.5.3 Flunixin Meglumine Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Flunixin Meglumine Injection Market Size by Region
4.1.1 Global Flunixin Meglumine Injection Sales Quantity by Region (2019-2030)
4.1.2 Global Flunixin Meglumine Injection Consumption Value by Region (2019-2030)
4.1.3 Global Flunixin Meglumine Injection Average Price by Region (2019-2030)
4.2 North America Flunixin Meglumine Injection Consumption Value (2019-2030)
4.3 Europe Flunixin Meglumine Injection Consumption Value (2019-2030)
4.4 Asia-Pacific Flunixin Meglumine Injection Consumption Value (2019-2030)
4.5 South America Flunixin Meglumine Injection Consumption Value (2019-2030)
4.6 Middle East and Africa Flunixin Meglumine Injection Consumption Value (2019-2030)
5.1 Global Flunixin Meglumine Injection Sales Quantity by Type (2019-2030)
5.2 Global Flunixin Meglumine Injection Consumption Value by Type (2019-2030)
5.3 Global Flunixin Meglumine Injection Average Price by Type (2019-2030)
6.1 Global Flunixin Meglumine Injection Sales Quantity by Application (2019-2030)
6.2 Global Flunixin Meglumine Injection Consumption Value by Application (2019-2030)
6.3 Global Flunixin Meglumine Injection Average Price by Application (2019-2030)
7.1 North America Flunixin Meglumine Injection Sales Quantity by Type (2019-2030)
7.2 North America Flunixin Meglumine Injection Sales Quantity by Application (2019-2030)
7.3 North America Flunixin Meglumine Injection Market Size by Country
7.3.1 North America Flunixin Meglumine Injection Sales Quantity by Country (2019-2030)
7.3.2 North America Flunixin Meglumine Injection Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Flunixin Meglumine Injection Sales Quantity by Type (2019-2030)
8.2 Europe Flunixin Meglumine Injection Sales Quantity by Application (2019-2030)
8.3 Europe Flunixin Meglumine Injection Market Size by Country
8.3.1 Europe Flunixin Meglumine Injection Sales Quantity by Country (2019-2030)
8.3.2 Europe Flunixin Meglumine Injection Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Flunixin Meglumine Injection Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Flunixin Meglumine Injection Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Flunixin Meglumine Injection Market Size by Region
9.3.1 Asia-Pacific Flunixin Meglumine Injection Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Flunixin Meglumine Injection Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Flunixin Meglumine Injection Sales Quantity by Type (2019-2030)
10.2 South America Flunixin Meglumine Injection Sales Quantity by Application (2019-2030)
10.3 South America Flunixin Meglumine Injection Market Size by Country
10.3.1 South America Flunixin Meglumine Injection Sales Quantity by Country (2019-2030)
10.3.2 South America Flunixin Meglumine Injection Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Flunixin Meglumine Injection Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Flunixin Meglumine Injection Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Flunixin Meglumine Injection Market Size by Country
11.3.1 Middle East & Africa Flunixin Meglumine Injection Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Flunixin Meglumine Injection Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Flunixin Meglumine Injection Market Drivers
12.2 Flunixin Meglumine Injection Market Restraints
12.3 Flunixin Meglumine Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Flunixin Meglumine Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Flunixin Meglumine Injection
13.3 Flunixin Meglumine Injection Production Process
13.4 Flunixin Meglumine Injection Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Flunixin Meglumine Injection Typical Distributors
14.3 Flunixin Meglumine Injection Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Flunixin Meglumine Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Flunixin Meglumine Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Norbrook Basic Information, Manufacturing Base and Competitors
Table 4. Norbrook Major Business
Table 5. Norbrook Flunixin Meglumine Injection Product and Services
Table 6. Norbrook Flunixin Meglumine Injection Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Norbrook Recent Developments/Updates
Table 8. Zoteis Basic Information, Manufacturing Base and Competitors
Table 9. Zoteis Major Business
Table 10. Zoteis Flunixin Meglumine Injection Product and Services
Table 11. Zoteis Flunixin Meglumine Injection Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Zoteis Recent Developments/Updates
Table 13. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 14. Merck Animal Health Major Business
Table 15. Merck Animal Health Flunixin Meglumine Injection Product and Services
Table 16. Merck Animal Health Flunixin Meglumine Injection Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Merck Animal Health Recent Developments/Updates
Table 18. Virbac Animal Health India Private Limited Basic Information, Manufacturing Base and Competitors
Table 19. Virbac Animal Health India Private Limited Major Business
Table 20. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Product and Services
Table 21. Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Virbac Animal Health India Private Limited Recent Developments/Updates
Table 23. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 24. MSD Animal Health Major Business
Table 25. MSD Animal Health Flunixin Meglumine Injection Product and Services
Table 26. MSD Animal Health Flunixin Meglumine Injection Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. MSD Animal Health Recent Developments/Updates
Table 28. Bengal Remedies Limited Basic Information, Manufacturing Base and Competitors
Table 29. Bengal Remedies Limited Major Business
Table 30. Bengal Remedies Limited Flunixin Meglumine Injection Product and Services
Table 31. Bengal Remedies Limited Flunixin Meglumine Injection Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Bengal Remedies Limited Recent Developments/Updates
Table 33. Wuhan Huisheng Biological Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Wuhan Huisheng Biological Technology Co., Ltd. Major Business
Table 35. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Product and Services
Table 36. Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Wuhan Huisheng Biological Technology Co., Ltd. Recent Developments/Updates
Table 38. Qilu Animal Health Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 39. Qilu Animal Health Products Co., Ltd. Major Business
Table 40. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Product and Services
Table 41. Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Qilu Animal Health Products Co., Ltd. Recent Developments/Updates
Table 43. Baimukang Animal Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Baimukang Animal Pharmaceutical Co., Ltd. Major Business
Table 45. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services
Table 46. Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Baimukang Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 48. Shandong Zhongmu Veterinary Medicine Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 49. Shandong Zhongmu Veterinary Medicine Co., Ltd. Major Business
Table 50. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Product and Services
Table 51. Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Developments/Updates
Table 53. Hebei New Century Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 54. Hebei New Century Pharmaceutical Co., Ltd. Major Business
Table 55. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services
Table 56. Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Hebei New Century Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 58. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 59. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Major Business
Table 60. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services
Table 61. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 63. Shandong Lukang Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 64. Shandong Lukang Pharmaceutical Co., Ltd. Major Business
Table 65. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Product and Services
Table 66. Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Shandong Lukang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 68. Global Flunixin Meglumine Injection Sales Quantity by Manufacturer (2019-2024) & (K Doses)
Table 69. Global Flunixin Meglumine Injection Revenue by Manufacturer (2019-2024) & (USD Million)
Table 70. Global Flunixin Meglumine Injection Average Price by Manufacturer (2019-2024) & (US$/Dose)
Table 71. Market Position of Manufacturers in Flunixin Meglumine Injection, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 72. Head Office and Flunixin Meglumine Injection Production Site of Key Manufacturer
Table 73. Flunixin Meglumine Injection Market: Company Product Type Footprint
Table 74. Flunixin Meglumine Injection Market: Company Product Application Footprint
Table 75. Flunixin Meglumine Injection New Market Entrants and Barriers to Market Entry
Table 76. Flunixin Meglumine Injection Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Flunixin Meglumine Injection Sales Quantity by Region (2019-2024) & (K Doses)
Table 78. Global Flunixin Meglumine Injection Sales Quantity by Region (2025-2030) & (K Doses)
Table 79. Global Flunixin Meglumine Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 80. Global Flunixin Meglumine Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 81. Global Flunixin Meglumine Injection Average Price by Region (2019-2024) & (US$/Dose)
Table 82. Global Flunixin Meglumine Injection Average Price by Region (2025-2030) & (US$/Dose)
Table 83. Global Flunixin Meglumine Injection Sales Quantity by Type (2019-2024) & (K Doses)
Table 84. Global Flunixin Meglumine Injection Sales Quantity by Type (2025-2030) & (K Doses)
Table 85. Global Flunixin Meglumine Injection Consumption Value by Type (2019-2024) & (USD Million)
Table 86. Global Flunixin Meglumine Injection Consumption Value by Type (2025-2030) & (USD Million)
Table 87. Global Flunixin Meglumine Injection Average Price by Type (2019-2024) & (US$/Dose)
Table 88. Global Flunixin Meglumine Injection Average Price by Type (2025-2030) & (US$/Dose)
Table 89. Global Flunixin Meglumine Injection Sales Quantity by Application (2019-2024) & (K Doses)
Table 90. Global Flunixin Meglumine Injection Sales Quantity by Application (2025-2030) & (K Doses)
Table 91. Global Flunixin Meglumine Injection Consumption Value by Application (2019-2024) & (USD Million)
Table 92. Global Flunixin Meglumine Injection Consumption Value by Application (2025-2030) & (USD Million)
Table 93. Global Flunixin Meglumine Injection Average Price by Application (2019-2024) & (US$/Dose)
Table 94. Global Flunixin Meglumine Injection Average Price by Application (2025-2030) & (US$/Dose)
Table 95. North America Flunixin Meglumine Injection Sales Quantity by Type (2019-2024) & (K Doses)
Table 96. North America Flunixin Meglumine Injection Sales Quantity by Type (2025-2030) & (K Doses)
Table 97. North America Flunixin Meglumine Injection Sales Quantity by Application (2019-2024) & (K Doses)
Table 98. North America Flunixin Meglumine Injection Sales Quantity by Application (2025-2030) & (K Doses)
Table 99. North America Flunixin Meglumine Injection Sales Quantity by Country (2019-2024) & (K Doses)
Table 100. North America Flunixin Meglumine Injection Sales Quantity by Country (2025-2030) & (K Doses)
Table 101. North America Flunixin Meglumine Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 102. North America Flunixin Meglumine Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 103. Europe Flunixin Meglumine Injection Sales Quantity by Type (2019-2024) & (K Doses)
Table 104. Europe Flunixin Meglumine Injection Sales Quantity by Type (2025-2030) & (K Doses)
Table 105. Europe Flunixin Meglumine Injection Sales Quantity by Application (2019-2024) & (K Doses)
Table 106. Europe Flunixin Meglumine Injection Sales Quantity by Application (2025-2030) & (K Doses)
Table 107. Europe Flunixin Meglumine Injection Sales Quantity by Country (2019-2024) & (K Doses)
Table 108. Europe Flunixin Meglumine Injection Sales Quantity by Country (2025-2030) & (K Doses)
Table 109. Europe Flunixin Meglumine Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Flunixin Meglumine Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Flunixin Meglumine Injection Sales Quantity by Type (2019-2024) & (K Doses)
Table 112. Asia-Pacific Flunixin Meglumine Injection Sales Quantity by Type (2025-2030) & (K Doses)
Table 113. Asia-Pacific Flunixin Meglumine Injection Sales Quantity by Application (2019-2024) & (K Doses)
Table 114. Asia-Pacific Flunixin Meglumine Injection Sales Quantity by Application (2025-2030) & (K Doses)
Table 115. Asia-Pacific Flunixin Meglumine Injection Sales Quantity by Region (2019-2024) & (K Doses)
Table 116. Asia-Pacific Flunixin Meglumine Injection Sales Quantity by Region (2025-2030) & (K Doses)
Table 117. Asia-Pacific Flunixin Meglumine Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 118. Asia-Pacific Flunixin Meglumine Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 119. South America Flunixin Meglumine Injection Sales Quantity by Type (2019-2024) & (K Doses)
Table 120. South America Flunixin Meglumine Injection Sales Quantity by Type (2025-2030) & (K Doses)
Table 121. South America Flunixin Meglumine Injection Sales Quantity by Application (2019-2024) & (K Doses)
Table 122. South America Flunixin Meglumine Injection Sales Quantity by Application (2025-2030) & (K Doses)
Table 123. South America Flunixin Meglumine Injection Sales Quantity by Country (2019-2024) & (K Doses)
Table 124. South America Flunixin Meglumine Injection Sales Quantity by Country (2025-2030) & (K Doses)
Table 125. South America Flunixin Meglumine Injection Consumption Value by Country (2019-2024) & (USD Million)
Table 126. South America Flunixin Meglumine Injection Consumption Value by Country (2025-2030) & (USD Million)
Table 127. Middle East & Africa Flunixin Meglumine Injection Sales Quantity by Type (2019-2024) & (K Doses)
Table 128. Middle East & Africa Flunixin Meglumine Injection Sales Quantity by Type (2025-2030) & (K Doses)
Table 129. Middle East & Africa Flunixin Meglumine Injection Sales Quantity by Application (2019-2024) & (K Doses)
Table 130. Middle East & Africa Flunixin Meglumine Injection Sales Quantity by Application (2025-2030) & (K Doses)
Table 131. Middle East & Africa Flunixin Meglumine Injection Sales Quantity by Region (2019-2024) & (K Doses)
Table 132. Middle East & Africa Flunixin Meglumine Injection Sales Quantity by Region (2025-2030) & (K Doses)
Table 133. Middle East & Africa Flunixin Meglumine Injection Consumption Value by Region (2019-2024) & (USD Million)
Table 134. Middle East & Africa Flunixin Meglumine Injection Consumption Value by Region (2025-2030) & (USD Million)
Table 135. Flunixin Meglumine Injection Raw Material
Table 136. Key Manufacturers of Flunixin Meglumine Injection Raw Materials
Table 137. Flunixin Meglumine Injection Typical Distributors
Table 138. Flunixin Meglumine Injection Typical Customers
List of Figures
Figure 1. Flunixin Meglumine Injection Picture
Figure 2. Global Flunixin Meglumine Injection Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Flunixin Meglumine Injection Consumption Value Market Share by Type in 2023
Figure 4. 10ml/Dose Examples
Figure 5. 20ml/ Dose Examples
Figure 6. Global Flunixin Meglumine Injection Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Flunixin Meglumine Injection Consumption Value Market Share by Application in 2023
Figure 8. Animal muscle pain Examples
Figure 9. Animal febrile disease Examples
Figure 10. Others Examples
Figure 11. Global Flunixin Meglumine Injection Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Flunixin Meglumine Injection Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Flunixin Meglumine Injection Sales Quantity (2019-2030) & (K Doses)
Figure 14. Global Flunixin Meglumine Injection Average Price (2019-2030) & (US$/Dose)
Figure 15. Global Flunixin Meglumine Injection Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Flunixin Meglumine Injection Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Flunixin Meglumine Injection by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Flunixin Meglumine Injection Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Flunixin Meglumine Injection Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Flunixin Meglumine Injection Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Flunixin Meglumine Injection Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Flunixin Meglumine Injection Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Flunixin Meglumine Injection Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Flunixin Meglumine Injection Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Flunixin Meglumine Injection Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Flunixin Meglumine Injection Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Flunixin Meglumine Injection Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Flunixin Meglumine Injection Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Flunixin Meglumine Injection Average Price by Type (2019-2030) & (US$/Dose)
Figure 30. Global Flunixin Meglumine Injection Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Flunixin Meglumine Injection Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Flunixin Meglumine Injection Average Price by Application (2019-2030) & (US$/Dose)
Figure 33. North America Flunixin Meglumine Injection Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Flunixin Meglumine Injection Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Flunixin Meglumine Injection Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Flunixin Meglumine Injection Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Flunixin Meglumine Injection Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Flunixin Meglumine Injection Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Flunixin Meglumine Injection Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Flunixin Meglumine Injection Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Flunixin Meglumine Injection Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Flunixin Meglumine Injection Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Flunixin Meglumine Injection Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Flunixin Meglumine Injection Consumption Value Market Share by Region (2019-2030)
Figure 53. China Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Flunixin Meglumine Injection Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Flunixin Meglumine Injection Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Flunixin Meglumine Injection Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Flunixin Meglumine Injection Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Flunixin Meglumine Injection Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Flunixin Meglumine Injection Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Flunixin Meglumine Injection Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Flunixin Meglumine Injection Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Flunixin Meglumine Injection Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Flunixin Meglumine Injection Market Drivers
Figure 74. Flunixin Meglumine Injection Market Restraints
Figure 75. Flunixin Meglumine Injection Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Flunixin Meglumine Injection in 2023
Figure 78. Manufacturing Process Analysis of Flunixin Meglumine Injection
Figure 79. Flunixin Meglumine Injection Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Norbrook Zoteis Merck Animal Health Virbac Animal Health India Private Limited MSD Animal Health Bengal Remedies Limited Wuhan Huisheng Biological Technology Co., Ltd. Qilu Animal Health Products Co., Ltd. Baimukang Animal Pharmaceutical Co., Ltd. Shandong Zhongmu Veterinary Medicine Co., Ltd. Hebei New Century Pharmaceutical Co., Ltd. Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Shandong Lukang Pharmaceutical Co., Ltd.
Related Reports
29 May 2021
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
